Chromosome X dosage modulates development of aneuploidy in genetically diverse mouse embryonic stem cells
Stem Cell Reports · 2026
DOI: 10.1016/j.stemcr.2026.102933 ↗Kurz gefasst
Fachartikel in der Zeitschrift Stem Cell Reports, 2026. Verfasst von Alexander Stanton und 17 weiteren Autor:innen. Beteiligte Einrichtung: The Jackson Laboratory, Bar Harbor, ME 04609, USA; Tufts Graduate School of Biomedical Sciences, Tufts University School of Medicine, Boston, MA 0211…. Hauptthemen laut MEDLINE: Aneuploidy, Mouse Embryonic Stem Cells, X Chromosome, Gene Dosage. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
The genetic integrity of pluripotent stem cells (PSC) is critical to their applications in research and therapy, but it is compromised by frequent development of structural chromosome variants associated with malignancy. Many PSC lines exhibit remarkable genetic stability, but little is known about the basis of the known variation in genomic integrity among different PSC isolates. Here, we identify aneuploidies using RNA-seq and proteomics data from a panel of mouse embryonic stem cell (mESC) lines derived from 170 Diversity Outbred mice. We found 62 lines with detectable aneuploid subpopulations and a subset of originally XX lines that lost one chromosome X (XO). Strikingly, a much lower proportion of XX lines were aneuploid, compared to XY or XO lines. Two single-cell RNA-seq datasets demonstrated that aneuploid XY DO mESC also show lower chromosome X gene expression, and a prospective study confirmed that XY mESC accumulate higher aneuploid proportions in culture than isogenic XX lines. We identify potential mechanisms for this protective effect of X chromosome dosage, including our findings that the lines with two active X chromosomes have a higher proportion of 2-cell-like cells and higher expression of X-linked tumor suppressor genes, both features associated with the maintenance of genomic integrity, and that they compete more robustly in co-culture with chromosomally abnormal cells than XY cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Jackson Laboratory, Bar Harbor, ME 04609, USA; Tufts Graduate School of Biomedical Sciences, Tufts University School of Medicine, Boston, MA 021111, USA.
- The Jackson Laboratory, Bar Harbor, ME 04609, USA.
- Department of Biomedical Science, University of Sheffield, Western Bank, Sheffield S10 2TN, UK.
- WiCell, Madison, WI 53719, USA.
- Department of Human Genetics, the University of Chicago, Chicago, IL 60637, USA.
- Predictive Biology Inc, Carlsbad, CA 92010, USA.
Förderung
- NCI NIH HHS
Zitieren
APA
Stanton, A., Aydin, S., Skelly, D. A., McGarr, T., Stavish, D., Leonhard, K., Taapken, S., Ludwig, T., McIntire, E., Pankratz, M., Czechanski, A., Choi, T., Gygi, S. P., Barbaric, I., Vierbuchen, T., Munger, S. C., Reinholdt, L. G., & Pera, M. F. (2026). Chromosome X dosage modulates development of aneuploidy in genetically diverse mouse embryonic stem cells. Stem Cell Reports. https://doi.org/10.1016/j.stemcr.2026.102933
Vancouver
Stanton A, Aydin S, Skelly DA, McGarr T, Stavish D, Leonhard K, et al. Chromosome X dosage modulates development of aneuploidy in genetically diverse mouse embryonic stem cells. Stem Cell Reports. 2026. doi:10.1016/j.stemcr.2026.102933
BibTeX
@article{Stanton2026,
author = {Stanton, Alexander and Aydin, Selcan and Skelly, Daniel A and McGarr, Tracy and Stavish, Dylan and Leonhard, Kim and Taapken, Seth and Ludwig, Tenneille and McIntire, Erik and Pankratz, Matthew and Czechanski, Anne and Choi, Ted and Gygi, Steven P and Barbaric, Ivana and Vierbuchen, Thomas and Munger, Steven C and Reinholdt, Laura G and Pera, Martin F},
title = {Chromosome X dosage modulates development of aneuploidy in genetically diverse mouse embryonic stem cells},
journal = {Stem Cell Reports},
year = {2026},
doi = {10.1016/j.stemcr.2026.102933}
}
EUVIMED